Androgen insensitivity syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 45: Line 45:
==Treatment==
==Treatment==
[[Androgen insensitivity syndrome medical therapy|Medical Therapy]] | [[Androgen insensitivity syndrome surgery|Surgery]] | [[Androgen insensitivity syndrome primary prevention|Primary Prevention]] | [[Androgen insensitivity syndrome secondary prevention|Secondary Prevention]] | [[Androgen insensitivity syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Androgen insensitivity syndrome future or investigational therapies|Future or Investigational Therapies]]
[[Androgen insensitivity syndrome medical therapy|Medical Therapy]] | [[Androgen insensitivity syndrome surgery|Surgery]] | [[Androgen insensitivity syndrome primary prevention|Primary Prevention]] | [[Androgen insensitivity syndrome secondary prevention|Secondary Prevention]] | [[Androgen insensitivity syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Androgen insensitivity syndrome future or investigational therapies|Future or Investigational Therapies]]
==Related Chapters==
* 17-hydroxylase deficiency syndrome
* 3-beta-hydroxysteroid dehydrogenase deficiency
* [[5-alpha-reductase deficiency]]
* [[Congenital adrenal hyperplasia]]
* Mayer-rokitansky syndrome





Revision as of 07:23, 31 August 2012

Androgen insensitivity syndrome
Testosterone (structure pictured) and dihydrotestosterone to a lesser degree, are the primary androgens involved in AIS.
ICD-10 E34.5
ICD-9 259.5
OMIM 312300 300068
DiseasesDB 29662 Template:DiseasesDB2
MeSH D013734

Androgen insensitivity syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Androgen insensitivity syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Androgen insensitivity syndrome On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Androgen insensitivity syndrome

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Androgen insensitivity syndrome

CDC on Androgen insensitivity syndrome

Androgen insensitivity syndrome in the news

Blogs on Androgen insensitivity syndrome

Directions to Hospitals Treating Androgen insensitivity syndrome

Risk calculators and risk factors for Androgen insensitivity syndrome

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Androgen resistance syndrome; complete androgen insensitivity; Goldberg-Morris syndrome; testicular feminization syndrome; incomplete androgen insensitivity; partial androgen insensitivity; Reifenstein syndrome; Gilbert-Dreyfus syndrome

Overview

Historical Perspective

Pathophysiology

Differentiating Androgen insensitivity syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | CT | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Related Chapters


androgen at NIH/UW GeneTests

de:Komplette Androgenresistenz it:Sindrome di Morris


Template:WikiDoc Sources